Evidence map›Paper›PMID 15645218›Full record

ReviewPsychopharmacology2005

Rate-dependent behavioral effects of stimulation of central motoric alpha(1)-adrenoceptors: hypothesized relation to depolarization blockade.

Eric A Stone, David Quartermain

Abstract readReview
PubMed Publisher
In one paragraph

Review in Psychopharmacology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eric A StoneDepartment of Psychiatry MHL HN510, NYU Med Ctr, 550 First Ave, New York, NY 10016, USA. es35@nyu.edu
David Quartermain
New York University · US

Funding

REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSIONR01MH045265 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI STONE, ERIC A · 2000 to 2010
$3.1M
REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSIONR37MH045265 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI STONE, ERIC A · 1989 to 1996
–
NIMH NIH HHS MH45265
6 · The paper itself

Abstract

aimThe purpose of this review is to clarify how central alpha(1)-adrenoceptors control behavioral activity under varying conditions of activity and stress.

methodThe literature is reviewed regarding the behavioral actions of alpha(1)-agonists and antagonists, and alpha(2)-agonists and antagonists under conditions of high and low baseline activity and stress.

resultsIt was found that alpha(1)-receptor stimulation of active behavior has a number of similarities to rate dependency including: (1) a dependence on low-active, low-stress conditions or on the prior depletion of endogenous brain catecholamines; (2) a nonmonotonic dose-response relationship with high doses producing a fall-off or actual depression of activity; (3) a failure to be blocked at high agonist doses by alpha(1)-antagonists; and (4) a facilitation by alpha(2)-adrenoceptor agonists which produce an opposing hyperpolarization. DISCUSSION: To explain these findings, it is proposed that high levels of stimulation of central alpha(1)-receptors produce, in host neurons, a depolarization block that impedes nerve impulse generation and inhibits active behavior. This effect is assumed to be precluded or mitigated by low-active, low-stress conditions, depletion of brain catecholamines, and by hyperpolarizing alpha(2)-agonists, and to be reversed at high agonist doses by alpha(1)-antagonists.

conclusionBecause brain alpha(1)-receptors are not only involved in motor activity but also in the mechanism of action of antidepressant and stimulant drugs, arousal, anxiety, stress and psychosis, a depolarization block from intense stimulation of these receptors could have broad psychopharmacological consequences and underlie rate dependency to a variety of stimulant drugs.

Indexed as

Adrenergic alpha-AgonistsAdrenergic alpha-AntagonistsAnimalsArousalBrainCatecholaminesHumansMiceMotor ActivityRatsReceptors, Adrenergic, alpha-1Adrenergic alpha-AgonistsAdrenergic alpha-AntagonistsCatecholaminesReceptors, Adrenergic, alpha-1

Identifiers

PMID15645218
OpenAlexW2018146913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.